UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Value in health, 2014, Vol.17 (1), p.5-14

2014

Link zum Volltext

Verfügbarkeit prüfen

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

Value in health, 2007-09, Vol.10 (5), p.336-347

2007

Link zum Volltext

Verfügbarkeit prüfen

Burden of cancer in Poland analysed using potential years of life lost

Contemporary oncology (Poznań, Poland), 2020-01, Vol.24 (1), p.13-16

2020

Link zum Volltext

Verfügbarkeit prüfen

Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset

BMJ open diabetes research & care, 2020-11, Vol.8 (2), p.e001773

2020

Link zum Volltext

Verfügbarkeit prüfen

NOS2 Polymorphism in Aspect of Left and Right-Sided Colorectal Cancer

Journal of clinical medicine, 2024-02, Vol.13 (4), p.937

2024

Link zum Volltext

Verfügbarkeit prüfen

GST gene family polymorphism and the risk of colorectal cancer in patients with type 2 diabetes

Studia medyczne, 2021-01, Vol.37 (3), p.218-225

2021

Link zum Volltext

Verfügbarkeit prüfen

Burden of suicide in Poland in 2012: how could it be measured and how big is it?

The European journal of health economics, 2018-04, Vol.19 (3), p.409-417

2018

Link zum Volltext

Verfügbarkeit prüfen

Burden of COVID-19 Mortality and Morbidity in Poland in 2020

International journal of environmental research and public health, 2022-04, Vol.19 (9), p.5432

2022

Link zum Volltext

Verfügbarkeit prüfen

An ecological study of the link between the risk of most frequent types of cancer in Poland and socioeconomic variables

International journal of public health, 2018-09, Vol.63 (7), p.777-786

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) on the risk of diabetic nephropathy: a meta-analysis

Polskie archiwum medycyny wewne̦trznej, 2015-01, Vol.125 (9), p.649-658

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of somatostatin analogues in the treatment of acromegaly

Expert review of pharmacoeconomics & outcomes research, 2019-01, Vol.19 (1), p.15-25

2019

Link zum Volltext

Verfügbarkeit prüfen

Glutathione S-Transferase P1 Genetic Variant's Influence on the HbA1c Level in Type Two Diabetic Patients

International journal of environmental research and public health, 2023-01, Vol.20 (2), p.1520

2023

Link zum Volltext

Verfügbarkeit prüfen

New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland

Multiple sclerosis, 2017-08, Vol.23 (2_suppl), p.130-142

2017

Link zum Volltext

Verfügbarkeit prüfen

Precision medicine for managing chronic diseases

Polskie archiwum medycyny wewne̦trznej, 2016-08, Vol.126 (9), p.681

2016

Link zum Volltext

Verfügbarkeit prüfen

Budget-Impact Analyses: A Critical Review of Published Studies

PharmacoEconomics, 2009-01, Vol.27 (10), p.807-827

2009

Link zum Volltext

Verfügbarkeit prüfen

Adherence to biologic DMARD therapies in rheumatoid arthritis

Expert opinion on biological therapy, 2010-09, Vol.10 (9), p.1367-1378

2010

Link zum Volltext

Verfügbarkeit prüfen

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Medical science monitor, 2011-04, Vol.17 (4), p.SR1-SR13

2011

Link zum Volltext

Verfügbarkeit prüfen

Proposal of Polish Guidelines for Conducting Financial Analysis and Their Comparison to Existing Guidance on Budget Impact in Other Countries

Value in health, 2004, Vol.7 (1), p.1-10

2004

Link zum Volltext

Verfügbarkeit prüfen

The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland

Value in health, 2002-09, Vol.5 (5), p.405-421

Orlewska, Ewa

2002

Link zum Volltext

Verfügbarkeit prüfen

LanroNET — A Non-Interventional Prospective Study to Assess the Resource Utilisation and Cost of Lanreotide Autogel 120 mg in the Population of Polish Patients with Symptomatic Neuroendocrine Tumours

Endokrynologia polska, 2018-09, Vol.69 (5), p.567-573

2018

Link zum Volltext

Verfügbarkeit prüfen

ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES

Acta Poloniae pharmaceutica, 2015-09, Vol.72 (5), p.1045-1050

2015

Link zum Volltext

Verfügbarkeit prüfen

Challenges in economic evaluation of new drugs: experience with rituximab in Hungary

Medical science monitor, 2010-01, Vol.16 (1), p.SR1-SR5

2010

Link zum Volltext

Verfügbarkeit prüfen

Dosage and costs of lanreotide Autogel 120 mg administered as part of routine acromegaly care in Poland - two years of data from Lanro-Study

Endokrynologia Polska, 2015, Vol.66 (2), p.142-148

2015

Link zum Volltext

Verfügbarkeit prüfen

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors - results of interim analysis

Contemporary oncology (Poznań, Poland), 2014-01, Vol.18 (6), p.442-447

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

Burden of cancer in Poland analysed using potential years of life lost

Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset

NOS2 Polymorphism in Aspect of Left and Right-Sided Colorectal Cancer

GST gene family polymorphism and the risk of colorectal cancer in patients with type 2 diabetes

Burden of suicide in Poland in 2012: how could it be measured and how big is it?

Burden of COVID-19 Mortality and Morbidity in Poland in 2020

An ecological study of the link between the risk of most frequent types of cancer in Poland and socioeconomic variables

Effects of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) on the risk of diabetic nephropathy: a meta-analysis

Cost-effectiveness of somatostatin analogues in the treatment of acromegaly

Glutathione S-Transferase P1 Genetic Variant's Influence on the HbA1c Level in Type Two Diabetic Patients

New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland

Precision medicine for managing chronic diseases

Budget-Impact Analyses: A Critical Review of Published Studies

Adherence to biologic DMARD therapies in rheumatoid arthritis

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Proposal of Polish Guidelines for Conducting Financial Analysis and Their Comparison to Existing Guidance on Budget Impact in Other Countries

The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland

LanroNET — A Non-Interventional Prospective Study to Assess the Resource Utilisation and Cost of Lanreotide Autogel 120 mg in the Population of Polish Patients with Symptomatic Neuroendocrine Tumours

ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES

The prevalence and direct costs of multiple sclerosis therapy in Poland from 2008 to 2016

Challenges in economic evaluation of new drugs: experience with rituximab in Hungary

Dosage and costs of lanreotide Autogel 120 mg administered as part of routine acromegaly care in Poland - two years of data from Lanro-Study

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors - results of interim analysis

Aktive Filter

Suchergebnisse filtern